Waters launches industry’s most sensitive and robust clinical IVD System with Xevo TQ Absolute XR IVD Mass SpectrometerJuly 31, 2026
General Combination therapy improves progression-free survival in dMMR/MSI-H metastatic colorectal cancerBy Healthcare Propulsion StaffJuly 30, 20260 Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the…